Titoli del Settore Sanitario
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 401 |  ESPR Esperion Therapeutics, Inc. | 2.17 USD | +5.85% | -5.24% | -14.57% | +119.19% | 557.28 M USD | ||
| 402 |  VALN Valneva SE American Depositary Shares | 6.03 USD | -0.99% | +1.86% | -41.74% | -12.74% | 523.22 M USD | ||
| 403 |  IMMX Immix Biopharma, Inc. Common Stock | 10.04 USD | +1.93% | +14.74% | -0.59% | +504.82% | 531.76 M USD | ||
| 404 |  NPCE Neuropace, Inc. Common Stock | 15.6100 USD | +1.69% | +6.05% | +9.16% | +47.54% | 525.54 M USD | ||
| 405 |  ADCT ADC Therapeutics SA | 4.36 USD | +12.08% | +17.20% | +3.32% | +269.49% | 553.91 M USD | ||
| 406 |  OFIX Orthofix Medical Inc. Common Stock (DE) | 12.8700 USD | +1.18% | +3.62% | +9.16% | -19.41% | 516.66 M USD | ||
| 407 |  STTK Shattuck Labs, Inc. Common Stock | 7.17 USD | +5.75% | +2.14% | +19.50% | +774.39% | 513.12 M USD | ||
| 408 |  AQST Aquestive Therapeutics, Inc. Common Stock | 4.24 USD | +2.17% | +2.91% | +5.21% | +66.93% | 517.47 M USD | ||
| 409 |  ALLO Allogene Therapeutics, Inc. Common Stock | 2.17 USD | -4.82% | -20.22% | -9.58% | +50.69% | 529.00 M USD | ||
| 410 |  ENGN enGene Therapeutics Inc. Common Stock | 7.7600 USD | +2.11% | +7.18% | +6.59% | -7.62% | 519.84 M USD | ||
| 411 |  FLGT Fulgent Genetics, Inc. Common Stock | 16.1700 USD | +0.94% | +2.21% | +8.82% | -31.57% | 505.00 M USD | ||
| 412 |  LRMR Larimar Therapeutics, Inc. Common Stock | 4.83 USD | -0.82% | -5.11% | +2.99% | +161.08% | 501.75 M USD | ||
| 413 |  LXEO Lexeo Therapeutics, Inc. Common Stock | 6.80 USD | +1.95% | +7.09% | +0.44% | +159.54% | 503.79 M USD | ||
| 414 |  STRO Sutro Biopharma, Inc. | 29.7700 USD | +3.44% | +9.85% | +28.76% | +71.19% | 493.21 M USD | ||
| 415 |  VREX Varex Imaging Corporation Common Stock | 11.78 USD | +0.34% | +7.09% | +6.80% | +54.39% | 493.58 M USD | ||
| 416 |  FDMT 4D Molecular Therapeutics, Inc. Common Stock | 9.7700 USD | +1.14% | -2.30% | +15.76% | -13.54% | 498.77 M USD | ||
| 417 |  KMDA Kamada Ltd | 8.44 USD | +0.24% | +1.20% | -3.87% | +32.08% | 486.87 M USD | ||
| 418 |  PACB Pacific Biosciences of California, Inc. | 1.60 USD | +1.91% | +8.84% | +17.65% | +26.98% | 483.20 M USD | ||
| 419 |  MYGN Myriad Genetics Inc | 5.1900 USD | +5.70% | +9.49% | +11.37% | -37.24% | 485.31 M USD | ||
| 420 |  RGNX REGENXBIO Inc. | 9.3600 USD | +0.65% | +9.60% | +7.59% | -30.31% | 483.10 M USD |
Notizie Titoli del Settore Sanitario
BofA alza il target su Hims and Hers per opzionalità sui peptidi
BofA alza il target su Ascendis Pharma per le vendite di Yorvipath
Humana dichiara un dividendo trimestrale di 0,885 dollari per azione
Leerink conferma rating Outperform su Structure Therapeutics
CareDx vende la divisione prodotti da laboratorio per 170 milioni di dollari in contanti
Le azioni QuidelOrtho crollano per le deboli previsioni sui ricavi
US-Iran Peace Hopes Push the S&P 500 and Nasdaq 100 to Record Highs
Gainers Titoli del Settore Sanitario
 IMMP Immutep Limited American Depositary Shares | 0.54 | +74.19% |
 CUE Cue Biopharma, Inc. | 0.72 | +63.64% |
 NOTV Inotiv, Inc. Common Stock | 0.39 | +56.00% |
 NIVFW NewGenIvf Group Limited Class A ordinary shares | 0.0194 | +45.86% |
 CDTTW CDT Equity Inc. Common Stock | 0.0085 | +41.67% |
 NXGL NexGel, Inc Common Stock | 0.76 | +28.81% |
 PDSB PDS Biotechnology Corporation Common Stock | 1.36 | +28.30% |
 TSHA Taysha Gene Therapies, Inc. Common Stock | 6.00 | +27.39% |
Losers Titoli del Settore Sanitario
 WORX SC WORX Corp | 1.06 | -30.72% |
 CMND Clearmind Medicine Inc. Common Shares | 0.65 | -28.57% |
 BEAT Heartbeam, Inc. Common Stock | 0.89 | -25.83% |
 TALKW Talkspace, Inc. Common Stock | 0.0016 | -23.81% |
 CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.0796 | -20.32% |
 JSPRW Jasper Therapeutics, Inc. Common Stock | 0.0166 | -20.19% |
 TOIIW The Oncology Institute, Inc. Common Stock | 0.0399 | -18.40% |
 ONCO Onconetix, Inc. Common Stock | 0.7615 | -16.32% |